Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
From the Fed's perspective, wage growth doesn't matter anymore.
Picking between the stocks of two industry leaders can be tough, as is the case with Nike and V.F. Corp.
The potential U.S.-China trade deal remains the single biggest event facing the market.
Grocery distributor SpartanNash is out front in the trend towards healthier food and beverage products, plus it has an enviable dividend yield.
Although the short squeeze wasn't as quick and swift as we thought it might be, it didn't disappoint in the end.
The yield has been in a downward trend since early November of last year as price has increased.
When you hear someone say that a curve inversion 'predicts' a recession, what it really means is that bond traders are 'predicting' a Fed rate cut.
This yield curve inversion has been a useful leading indicator of a recession, but what really matters is whether it is a signal we can profit from.
If it weren't for its smaller market cap, this footwear company would be on the list of Dividend Aristocrats.